He restarted Dilantin last night.
He received Ativan 2mg IV x1 at 12:36pm and another 2mg at 12:41pm.
Nasal trumpet and foley placed.
Coronary artery disease status post myocardial infarction in [**2089**].
History of deep vein thrombosis treated with coumadin x 6 months.
Pertinent Results: [**2101-11-6**] 09:08PM   PHENYTOIN-12.4  [**2101-11-11**] PHENYTOIN 13  [**2101-11-6**] 08:06PM   TYPE-ART TEMP-37.7 RATES-[**11-7**] TIDAL VOL-650 PEEP-5 O2-100 PO2-409* PCO2-40 PH-7.44 TOTAL CO2-28 BASE XS-3 AADO2-295 REQ O2-53 -ASSIST/CON INTUBATED-INTUBATED  [**2101-11-6**] 02:41PM   LACTATE-3.8*  [**2101-11-6**] 02:30PM CEREBROSPINAL FLUID (CSF)  PROTEIN-40 GLUCOSE-81 [**2101-11-6**] 02:30PM CEREBROSPINAL FLUID (CSF)  WBC-6 RBC-28* POLYS-52 LYMPHS-44 MONOS-5 [**2101-11-6**] 02:30PM CEREBROSPINAL FLUID (CSF)  WBC-3 RBC-[**Numeric Identifier 42606**]* POLYS-73 LYMPHS-17 MONOS-10 CSF culture negative  [**2101-11-6**] 01:00PM   ASA-NEG ETHANOL-NEG ACETMNPHN-NEG bnzodzpn-NEG barbitrt-NEG tricyclic-NEG [**2101-11-6**] 01:00PM URINE  bnzodzpn-NEG barbitrt-NEG opiates-NEG cocaine-NEG amphetmn-NEG mthdone-NEG  CT brain: No evidence of recent hemorrhage.
Dilantin had recently been held secondary to supratherapeutic level of 30, and patient had only resumed Dilantin morning of admission.
Patient was loaded with Dilantin IV and admitted to ICU setting.
Also received IV ativan.
Was intubated for airway protection.
Full strength throughout aside from pain limitation around R shoulder.
Renal dose Keppra was started [**2101-11-9**] (in place of Trileptal given concerns regarding CRI and hyponatremia on Trileptal).
Will remain on dual therapy of PHT and Keppra until Keppra is at full dose.
Appointment with Dr [**Last Name (STitle) **] and [**Doctor Last Name **] on [**2101-11-24**] and prescription given for check keppra level on that day.
Will require monitoring of dilantin level to ensure continued therapeutic level on reduced maintenance dose while keppra increasing, as discussed with Dr [**First Name (STitle) 3510**].
Antihypertensives continued and iv metoprolol x1 on [**2101-11-9**].
Resp: intubated day 1 for airway protection and extubated overnight.
Cr improved to 1.3 on discharge with additional fluids.
Endo: covered with regular insulin sliding scale.
Pain improved with acetaminophen and ibuprofen.
Medications on Admission: Aspirin 325 mg po DAILY Dilantin 200mg [**Hospital1 **]  100mg daily Gabapentin 100 mg TID Digoxin 125 mcg PO DAILY Labetalol 400mg PO BID Hydrochlorothiazide 25 mg PO once a day Amoxycillin 500mg po QID for cough (5 doses remaining) Atorvastatin 20mg  PO DAILY  Discharge Medications: 1.
Aspirin 325 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Gabapentin 100 mg Capsule Sig: One (1) Capsule PO TID (3 times a day).
Digoxin 125 mcg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Ibuprofen 400 mg Tablet Sig: One (1) Tablet PO Q8H (every 8 hours) as needed for shoulder pain.
Dilantin 30 mg Capsule Sig: One (1) Capsule PO at bedtime: Take with 2 100mg capsules to make total 230mg at night.
Atorvastatin 40 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Levetiracetam 500 mg Tablet Sig: One (1) Tablet PO BID (2 times a day): From [**2101-11-18**] take 1 and 1/2 tablets ie.
Labetalol 200 mg Tablet Sig: Two (2) Tablet PO BID (2 times a day).
Hydrochlorothiazide 25 mg Tablet Sig: One (1) Tablet PO once a day.
Discharge Disposition: Home With Service  Facility: [**Location (un) 86**] VNA  Discharge Diagnosis: Status Epilepticus Renal Insufficiency R shoulder strain   Discharge Condition: No seizures; R shoulder remained tender and was managed with a sling and follow up PT.
Followup Instructions: * Call for appointment with Dr [**First Name (STitle) 3510**] (ph [**Numeric Identifier 98008**]) on Monday or Tuesday next week for review and check blood chemistry and dilantin level.
